Related Experiment Video
Updated: Dec 11, 2025

A Novel Rescue Technique for Difficult Intubation and Difficult Ventilation
Published on: January 17, 2011
Epistaxis management on COVID-19-positive patients: Our early case experience and treatment
Samba Siva R Bathula1, Tyler Patrick1, Luxman Srikantha1
1Department of Otolaryngology - Head and Neck Surgery Detroit Medical Center Detroit MI USA.
Insights
Managing nosebleeds in COVID-19 patients requires caution due to high viral load. Initial treatment involves oxymetazoline drops and pressure, with absorbable packing as a secondary option to minimize healthcare worker exposure.
Area of Science:
- Otolaryngology
- Infectious Diseases
- Respiratory Medicine
Background:
- Epistaxis (nosebleeds) in patients with COVID-19 presents unique management challenges.
- The high virulence and concentration of SARS-CoV-2 in respiratory droplets and nasal secretions raise concerns for healthcare providers.
Observation:
- Standard epistaxis management protocols may increase the risk of viral transmission.
- Otolaryngologists must balance effective hemostasis with infection control measures.
Findings:
- Initial epistaxis management should prioritize non-invasive methods like oxymetazoline nasal drops and direct external pressure.
- Nasal packing, particularly with absorbable materials, should be considered only after less invasive measures are insufficient.
Implications:
- This approach aims to reduce aerosol generation and direct contact with infectious nasal secretions.
- Implementing these strategies can enhance the safety of healthcare workers managing epistaxis in COVID-19 patients.
Abstract:
Epistaxis management on COVID-19 patients is concerning for otolaryngologists due to the highly virulence and increased concentration within respiratory droplets and nasal secretions. Authors suggest initial management with oxymetazoline nasal drops and local pressure before considering nasal packing with absorbable material to prevent COVID-19 transmission to surrounding healthcare workers.
More Related Videos
09:03Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Epistaxis
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
Suctioning the Nasopharyngeal Airway
Equipment Required
Cardiopulmonary Resuscitation II: ACLS Airway Management
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Tracheostomy Decannulation
Description of the Procedure
Decannulation refers to the permanent removal of the tracheostomy tube, signaling the resolution of the condition that initially necessitated the tracheostomy. The process requires a well-coordinated interplay between...
Endoscopic Studies II: Thoracocentesis
Description
Excess pleural fluid or air may accumulate in some respiratory disorders in the thoracic cavity. To treat pleural effusion, a physician conducts thoracentesis by carefully piercing the chest wall and entering...